HomeSearchGlobal LocationsContact UsGenzyme Websites
About GenzymeOur ResearchOur ProductsOur Commitment
Genzyme

Corporate Info
Investors
News
Press Contacts
News Subscription
Partnering
Genzyme Events
Careers
Global Locations

News

Press Releases

Year: 2012 | 2011 | 2010 | 2009 | 2008

May 3, 2012Genzyme Announces Regulatory Approvals of Expanded Waterford, Ireland Manufacturing Plant

April 24, 2012Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received LemtradaTM* (Alemtuzumab) Compared With Rebif® in Phase III Trial

April 20, 2012Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple Sclerosis Phase lll Trials

April 19, 2012Genzyme’s Biologics Support Center Achieves LEED Gold Rating for Environmentally Responsible Design

April 16, 2012Genzyme and Veracyte Announce Expanded U.S. Availability of the Afirma® Thyroid FNA Analysis for Improved Thyroid Nodule Diagnosis

March 29, 2012Genzyme and Isis Announce Submission of U.S. NDA for KYNAMRO™ (mipomersen sodium) in Homozygous Familial Hypercholesterolemia

March 29, 2012KYNAMRO™ (mipomersen sodium) Data Presented at XVI International Symposium on Atherosclerosis

March 1, 2012Genzyme Begins Shipping Fabrazyme from Newly Approved Framingham Manufacturing Plant

February 29, 2012Genzyme Recognizes International Rare Disease Day with Second Annual Patient Advocacy Grant Program

February 23, 2012Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis

February 8, 2012Four-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Continued Improvement Across All Endpoints

January 24, 2012Genzyme Announces FDA Approval of Framingham Manufacturing Plant

January 20, 2012Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients

January 18, 2012Genzyme Announces European Approval of Framingham Manufacturing Plant




CONTACT INFORMATION:
Genzyme Media Relations
500 Kendall Street
Cambridge, MA 02142
T 617 252 7570
F 617 374 7368
Email Media Relations

Terms and Conditions of Use | Privacy Policy | © 2002-2012 Genzyme Corporation, a Sanofi company. All rights reserved.